Updated October 7, 2026 · By Rob Braddock
Biopharmaceutical GMP readiness starts with identifying the requirements for the product, activity, development stage, and intended market. It then requires an evidence based plan for facilities, people, processes, and the quality system. A general article cannot establish compliance or replace a product specific regulatory assessment.
Confirm the Applicable Framework
In the United States, start with FDA’s CGMP regulations overview and determine which provisions apply to the activity. In the EU, use EMA’s compliance overview and the applicable European Commission GMP guidance with qualified regulatory specialists. EU oversight involves EMA and national competent authorities; it is not a single uniform approval step managed by EMA alone.
Separate marketing authorization, clinical development requirements, manufacturing controls, and site permissions. They are related, but completing one does not automatically satisfy the others. Record the source and rationale for each applicable requirement.
Build a Requirement and Evidence Register
| Planning area | Question | Evidence or action |
|---|---|---|
| Responsibilities | Who owns execution and quality decisions? | Defined roles, escalation, and review responsibilities |
| Facilities and equipment | Are the intended uses supported? | Qualification, maintenance, calibration, and relevant assessments |
| Materials | Are receipt, status, and use controlled? | Specifications, supplier assessments, and traceability |
| Procedures and training | Can staff perform the approved work? | Current instructions and training evidence |
| Records and data | Can decisions be traced to reliable information? | Complete records, access controls, and review arrangements |
| Exceptions and changes | Are issues assessed and followed through? | Investigations, corrective actions, and change records |
Assess the Quality System in Daily Work
FDA’s ICH Q10 guidance describes a pharmaceutical quality system model. An operational review should examine how the site’s system works in practice, including responsibilities, review, and follow through. A procedure existing in a document system does not show that the activity is performed effectively.
- Trace a recent batch and its supporting records through the review process.
- Check whether changes were assessed before implementation.
- Review recurring issues and the evidence that corrective actions worked.
- Confirm that training matches the current approved process.
- Examine handoffs between manufacturing, engineering, laboratories, and quality.
Prepare for Inspection Through Routine Readiness
Keep evidence organized and retrievable as part of normal work. Assign subject owners who can explain the process and locate supporting records. Track unresolved gaps with risk, owner, target date, and required evidence. Address missing or inconsistent information through the approved system rather than reconstructing a favorable account for an inspection.
EMA’s GMP and GDP questions and answers includes data integrity guidance. Use current official sources and check their scope for the product and activity.
Illustrative Readiness Gap
Suppose a critical instrument is in service but the team cannot locate its current calibration evidence. The response is to establish its status, assess the impact, and address the issue through the responsible quality and technical owners. This hypothetical example shows why readiness depends on verifiable evidence rather than verbal assurance.
Frequently Asked Questions
Does a successful inspection guarantee continuing compliance?
No. Readiness must be maintained as operations, people, products, and requirements change.
Can an efficiency project remove quality controls?
Assess proposed changes against the applicable requirements and intended process. Keep the appropriate quality and regulatory decision makers involved.
Where should an operational review begin?
Use our pharmaceutical manufacturing site assessment guide to connect requirements with the batch journey and daily work.
Discuss Your Manufacturing Priorities
PharmExcel helps leaders assess manufacturing readiness, systems, staffing, and improvement priorities and turn findings into practical actions. Contact Rob to discuss your priorities or explore our consulting services.
About the Author
Rob Braddock founded PharmExcel Consulting after manufacturing leadership roles at Evergreen Theragnostics, BioCentriq, Pfizer/Wyeth Vaccines, and Chemtrade. His consulting work focuses on manufacturing operations, systems, and organizational development.